GLP-1 (S) + Cagrilinitide Blend

GLP-1 (S) + Cagrilintide – Research-Grade Dual Peptide Blend

This formulation consists of two structurally distinct, long-acting synthetic
peptide analogs: a glucagon-like peptide-1 (GLP-1) receptor agonist analog and
a modified amylin analog. Each peptide is independently synthesized and
characterized, then combined in defined proportions to create a reproducible
dual-peptide research system.

In laboratory research environments, this blend is utilized as a reference
material for studying multi-receptor peptide interaction models, comparative
signaling pathway analysis, and structure–function relationships associated
with long-acting peptide analogs. The defined composition allows controlled
investigation of peptide stability, receptor-binding dynamics, and
combination peptide behavior under in vitro experimental conditions.

Unlike intact proteins or complex biologic mixtures, this formulation
represents a precisely manufactured dual-peptide construct designed to
support mechanistic assays and exploratory biochemical research. This
material is intended strictly for laboratory research use only and is not
designed for human or veterinary application.